Novartis, Vanda in Fanapt deal

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) granted Novartis AG (NYSE:NVS; SIX:NOVN) exclusive rights in the U.S. and Canada to develop and commercialize Fanapt iloperidone. The drug is approved in the U...